Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes

doi:10.3748/wjg.v21.i27.8293

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8718)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

577

WORD

291

HTML

4634

Figures (1-2)

202

Tables (1-1)

176

Sum=5880

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1152

Download

1686

Sum=2838

Jul 21, 2015 (publication date) through Aug 26, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 21, 2015; 21(27): 8293-8303
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8293

Full Size Figure Download Figure

Figure 2 Hepatitis C virus-mediated perturbations in cholesterol metabolism. HCV: Hepatitis C virus; ROS: Reactive oxygen species; VLDL: Very low-density lipoprotein.

Citation: Simon TG, Butt AA. Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes. World J Gastroenterol 2015; 21(27): 8293-8303
URL: https://www.wjgnet.com/1007-9327/full/v21/i27/8293.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i27.8293